Some people with chronic obstructive pulmonary disease (COPD) need to use multiple inhaled medicines each day to control their symptoms. Long-acting combination inhalers that contain more than one ...

The FDA approved United Kingdom-based GlaxoSmithKline’s Trelegy Ellipta, a once-daily inhaler that contains three medicines for chronic obstructive pulmonary disease. The inhaler, developed with the ...

Symbicort is an inhaler used for long-term control of asthma and COPD, but it is not a rescue inhaler. Before using Symbicort, tell your healthcare provider if you have health conditions like adrenal ...

Millions of asthma, chronic bronchitis and emphysema sufferers can now begin ordering a Raleigh-based firm's new breath-activated devices for inhalers that are designed to improve drug delivery. While ...

Please provide your email address to receive an email when new articles are posted on . Icenticaftor did not yield a dose response for trough FEV 1 at 12 weeks, but treatment was associated with ...

Q. I have COPD, chronic obstructive pulmonary disease. My doctor tells me that my main problem is chronic bronchitis, but I also have some mild emphysema. I quit smoking four years ago. I'm on three ...